Details of the Drug Reposition

General Information of This Drug (ID: DMZUV7T)

Drug Name
CART-19 cells   DMZUV7T
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphocytic leukaemia DISPX75S 2B33.3 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02794246) CART-19 Post-ASCT for Multiple Myeloma
2 ClinicalTrials.gov (NCT01551043) Allo CART-19 Protocol